The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …

Femoropopliteal lesions account for a significant proportion of endovascular interventions
for peripheral artery disease in patients with disabling claudication or chronic limb ischemia …

Purpose: To report the 36-month outcomes from the prospective, multicenter, single-arm IN.
PACT Global Study (ClinicalTrials. gov identifier NCT01609296) evaluating the performance …

Background Stent‐based revascularization of long femoro‐popliteal (FP) lesions has been
mainly studied in claudicants and compromised by restenosis and stent fractures. The …

In-stent restenosis is a pervasive challenge to the durability of stenting for the treatment of
lower extremity ischemia. There is considerable controversy about the criteria for diagnosis …

Several meta-analyses and multicenter trials have shown that chronic limb ischemia did not
occur for up to 5 years in 50%–70% of patients who underwent saphenous vein grafts, with …

Background Reports our experience for the first 50 cases of use of Supera stent for popliteal
atherosclerotic lesions treatment. Methods This prospective single-arm trial enrolled the first …

Purpose: To report a randomized trial comparing the Legflow paclitaxel-eluting balloon
(PEB)+ Supera stenting to Supera stenting alone in patients with intermediate to long …

Purpose: The performance of self-expanding interwoven nitinol stent (Supera) in
femoropopliteal interventions has been proven through trials with short lesions and with …

Purpose: To evaluate the safety and midterm patency of the Supera interwoven nitinol stent
in a real-world population and determine deployment and patient-related factors that may …